Article

Alfa Chemistry Newly Releases the Offering of Forensic and Veterinary Standards

Topic: Business DevelopmentPublished May 16, 2022

Legacy signals

Legacy popularity: 358 legacy views

Through years of dedicated efforts, Alfa Chemistry has become one of the most popular suppliers of analytical reagents among customers across the globe. Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research. Forensic veterinary medicine has gained increasing importance year by year. Animals are involved in litigation for possible reasons like unexpected death, welfare, abuse, and breaches of conservation law. “Forensic work requires a different set of skills from routine diagnosis and treatment, and while using analytical instrumentation, the forensic and veterinary standards are often something used to help achieve the optimal performance and compliance,” says the Marketing Chief of Alfa Chemistry. “Now we provide four types of such standards, including clinical chemistry CRM, drugs & metabolites, drugs of abuse, and steroids/doping agents standards.” Drugs & Metabolites Standards Used in Forensic and VeterinaryrnDrug & metabolite standards are an important class of reference materials that have important application value for separation analysis in the pharmaceutical industry, animal husbandry, forensic appraisal and veterinary drug research, providing convenience for many identification and analysis fields. Some of the drug & metabolite standards that Alfa Chemistry provides are: ipronidazole-oh-(n-methyl-d3) (cas 1156508-86-9), salbutamol-(tert-butyl-d9) acetate (cas 1173021-73-2), flumequine-(1,2,carboxy-13c3) (cas 1185049-09-5), metformin-(dimethyl-d6) hydrochloride (cas 1185166-01-1 ), nalidixic acid-(ethyl-d5) (cas 1189467-36-4), salicylic acid (phenyl-13c6) (cas 1189678-81-6), cimaterol-d7 (cas 1228182-44-2), etc. Drugs of Abuse StandardsrnDrug abuse can cause serious harm to society and production. To regulate drug use and maintain health and safety, it is necessary to formulate complete and accurate drug standards and strengthen the purchase management of such drugs. The drugs of abuse standards offered by Alfa Chemistry can provide reliable and convenient data support for related research fields, and formulate response standards and management systems, which covers: AH 11110 (cas 179388-65-9), sulindac (cas 38194-50-2), (z)-guggulsterone (cas 39025-23-5), pilocarpine hydrochloride (cas 54-71-7), hydromorphone hydrochloride (cas 71-68-1), anisotropine methyl bromide (cas 80-50-2), and kavergal 1. Steroids/Doping Agents StandardsrnThe use of steroids and doping agents should be standardized. Steroids and doping agent standards are thus widely used to identify whether there is any abuse of steroid and doping agents. They can make the analysis more convenient, accurate and efficient. At Alfa Chemistry, you can easily find such standards like metoprolol tartrate (cas 56392-17-7), (s)-3-(4-chloro-3-fluorophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3 trifluoromethylphenyl)propionamide (cas 596096-86-5), 2-chloro-3-methyl-4-[(7r,7as)-tetrahydro-7-hydroxy-1,3-dioxo-1h-pyrrolo[1,2-c]imidazol-2(3h)-yl]benzonitrile (cas 627530-84-1), omeprazole (cas 73590-58-6), 4-[(3-endo)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]naphthalene-1-carbonitrile (cas 870888-46-3), 2,3,4,5-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine (cas 927871-76-9) and more. Clinical Chemistry CRMrnHuman apolipoprotein A I (mass concentration) can be used for clinical chemistry CRM. As always, Alfa Chemistry is at the forefront of technical innovation, strictly follows the regulatory compliance, and strives to provide the best quality reagents and standards for customers worldwide. Visit https://reagents.alfa-chemistry.com/products/forensic-and-veterinary-standards-647.html to learn more.

Further reading

Further Reading

4 total

Article

Artificial intelligence continues to dominate business conversations, but enthusiasm alone does not guarantee results. While many companies rush to adopt AI in hopes of gaining a competitive edge, a large number of initiatives still fall short. The problem is rarely the technology itself. More often, failure happens because organizations approach AI without the structure, readiness, and discipline required for long-term success. AI projects do not fail because the technology

March 4, 2026

Article

AI Avatar Development: Real Innovation or Just Hype? In today’s hyperconnected world, attention is currency. To stand out, brands can no longer settle for flashy features or surface-level engagement. They need to build meaningful, scalable, and personalized experiences. Enter AI avatars: digital humans that are revolutionizing communication by bringing lifelike presence to virtual interactions. Imagine a team member who never takes a coffee break, speaks ten languages fluen

February 27, 2026

Article

The Quiet Engine Behind Every Connection Most people think of telecom services as towers, signals, and mobile data moving invisibly through the air. Yet behind every call that connects and every message that reaches its destination, there is another system quietly working in the background. That system is the call center. While customers often interact with telecom companies only when something goes wrong, these centers operate constantly, guiding problems toward solutions an

February 23, 2026

Article

Introduction The solar industry once believed that collecting as many leads as possible was the fastest path to growth. Marketing teams focused on filling databases with names, phone numbers, and email addresses. At first, the numbers looked promising. Dashboards showed rising interest and more inquiries than ever before. Yet behind the scenes, many companies began to notice a quiet problem. Revenue growth did not match the flood of leads. Sales teams felt overwhelmed, conver

February 6, 2026